Editorial Disclaimer: Smart Update24 verifies information through official websites, government notifications, and trusted sources before publication. Our team also conducts independent research and analysis to provide accurate information to readers; however, users are advised to verify important details from the respective official websites for final confirmation.
PCI 37th Skill Development Programme on Pharmacovigilance 2026: The Pharmacy Council of India (PCI) has announced the 37th Skill Development Programme on Pharmacovigilance, a specialized training initiative aimed at strengthening knowledge and practical skills related to drug safety monitoring and adverse drug reaction reporting. The
The programme will be conducted in offline classroom mode from June 15 to June 19, 2026, at the National Coordination Centre – Pharmacovigilance Programme of India (NCC-PvPI), Indian Pharmacopoeia Commission (IPC), Ghaziabad. The initiative is expected to benefit pharmacy students, healthcare professionals, academicians, and industry experts interested in the rapidly growing field of pharmacovigilance.
PCI 37th Skill Development Programme: What Is the Pharmacovigilance Skill Development Programme?
Pharmacovigilance plays a crucial role in ensuring the safety and effectiveness of medicines after they reach the market. Through this training programme, participants will gain practical exposure to drug safety monitoring systems, adverse drug reaction (ADR) reporting mechanisms, and regulatory practices followed in India.
The programme is being organized by the NCC-PvPI under the Indian Pharmacopoeia Commission, which functions under the Ministry of Health and Family Welfare, Government of India.
Programme Schedule
| Particulars | Details |
| Programme Name | 37th Skill Development Programme on Pharmacovigilance |
| Mode | Offline Classroom Training |
| Dates | 15 June to 19 June 2026 |
| Venue | NCC-PvPI, Indian Pharmacopoeia Commission, Ghaziabad |
| Registration Deadline | 8 June 2026 |
| Registration Fee | Rs. 5,000 (Including GST) |
Who Can Participate?
The training programme is open to a wide range of participants from the healthcare and pharmaceutical sectors.
Eligible participants include:
- Pharmacy/Pharm.D/MBBS students/BDS/Nursing students
- Healthcare Professionals in Pharmacovigilance
- Pharmacists/Doctors/Nurses
- Academicians
- Industry professionals
- Consumers and NGOs
PCI 37th Skill Development Programme: Key Learning Opportunities
Participants attending the five-day programme will receive hands-on exposure to several important aspects of pharmacovigilance, including:
- Adverse Drug Reaction (ADR) reporting procedures
- Data entry and quality review of Individual Case Safety Reports (ICSRs)
- Signal detection methodologies in pharmacovigilance
- ADR Monitoring Centre operations
- Visit to IPC facilities
- Understanding regulatory frameworks for drug safety monitoring
The programme has been designed to bridge the gap between theoretical knowledge and real-world pharmacovigilance practices, helping participants develop industry-relevant skills.
Official Notification: Download
Why This Programme Matters
As healthcare systems increasingly focus on patient safety, the demand for professionals trained in pharmacovigilance continues to grow. Knowledge of adverse event monitoring, drug safety assessment, and regulatory compliance has become valuable for pharmacists, doctors, researchers, and healthcare organizations.
Participation in this programme can help students and professionals understand how medical safety is monitored at the national level while also improving career prospects in pharmaceutical companies, hospitals, research organizations, and regulatory agencies.
PCI 37th Skill Development Programme: Certificate After Completion
According to the programme details, participants who successfully complete the training will receive a certificate, adding value to their academic and professional credentials.
Registration Deadline Approaching
Interested candidates must complete their registration before June 8, 2026. Since seats are limited, applicants are advised to register early to secure participation in the programme. The training will take place at the Indian Pharmacopoeia Commission campus in Ghaziabad from June 15 to June 19, 2026.
